Treatment will depend on your child’s symptoms, age, and general health. It will also depend on how severe the condition is. Nearly half of all children with JIA recover fully. Others may have ...
UNLOXCYT (cosibelimab-ipdl) is indicated for the treatment of adults with metastatic cutaneous squamous cell carcinoma (“cSCC”) or locally advanced cSCC who are not candidates for curative surgery or ...